(Q34587175)

3 August 2017

1 reference

title

The human T cell response to melanoma antigens (English)

1 reference

3 August 2017

Pedro Romero

1

1 reference

3 August 2017

Jean-Charles Cerottini

series ordinal

2

1 reference

3 August 2017

Daniel E Speiser

series ordinal

3

1 reference

3 August 2017

publication date

1 January 2006

1 reference

3 August 2017

published in

Advances in Immunology

1 reference

3 August 2017

volume

92

1 reference

3 August 2017

page(s)

187-224

1 reference

Tuning tumor-specific T-cell activation: a matter of costimulation?

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Toll-like receptors: critical proteins linking innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

The physiological role of cytotoxic CD4(+) T-cells: the holy grail?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Lessons from the study of T-cell differentiation in persistent human virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Decreased specific CD8+ T cell cross-reactivity of antigen recognition following vaccination with Melan-A peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

CD4+ T cell responses to SSX-4 in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

MHC multimer technology: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Tumor antigen expression in melanoma varies according to antigen and stage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Molecular-genetic imaging: current and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Human T cell responses against melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Regulation of immune responses by L-arginine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Costimulatory regulation of T cell function.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Final antigenic Melan-A peptides produced directly by the proteasomes are preferentially selected for presentation by HLA-A*0201 in melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Effect of CD4+CD25+ and CD4+CD25- T regulatory cells on the generation of cytolytic T cell response to a self but human tumor-associated epitope in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

High avidity antigen-specific CTL identified by CD8-independent tetramer staining

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Vaccination in humans generates broad T cell cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8(+) T-cells by flow cytometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Interferon-gamma or granulocyte-macrophage colony-stimulating factor administered as adjuvants with a vaccine of irradiated autologous tumor cells from short-term cell line cultures: a randomized phase 2 trial of the cancer biotherapy research group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Maximizing the retention of antigen specific lymphocyte function after cryopreservation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Molecular imaging of cancer with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Spying on cancer: molecular imaging in vivo with genetically encoded reporters

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Cycloxygenase-2 inhibition augments the efficacy of a cancer vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Analysis of a rare melanoma patient with a spontaneous CTL response to a MAGE-A3 peptide presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Well-defined melanoma antigens as progression markers for melanoma: insights into differential expression and host response based on stage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

CD4+CD25+ regulatory T cells that secrete TGFbeta and IL-10 are preferentially induced by a vaccine vector

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Helper role of NK cells during the induction of anticancer responses by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Local delivery of vaccinia virus expressing multiple costimulatory molecules for the treatment of established tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Measuring Ag-specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

An essential role for Scurfin in CD4+CD25+ T regulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

The fluorolysis assay, a highly sensitive method for measuring the cytolytic activity of T cells at very low numbers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Medicine. The need for a global HIV vaccine enterprise

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Standardization of cytokine flow cytometry assays

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Recent advances in tumour antigen-specific therapy: in vivo veritas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Cytokine flow cytometry: a multiparametric approach for assessing cellular immune responses to viral antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Clonal selection of helper T cells is determined by an affinity threshold with no further skewing of TCR binding properties

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Control of T cell viability

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

The role of programming in memory T-cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Evolution of antigen-specific T cell receptors in vivo: preimmune and antigen-driven selection of preferred complementarity-determining region 3 (CDR3) motifs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Innate immunity: impact on the adaptive immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome-deficient melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

IDO expression by dendritic cells: tolerance and tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Quantum dots for live cells, in vivo imaging, and diagnostics

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Tinkering with nature: the tale of optimizing peptide based cancer vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Quiescent phenotype of tumor-specific CD8+ T cells following immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Targeted contrast agents for magnetic resonance imaging and ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Natural killer cells and dendritic cells: rendezvous in abused tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Tetramer analysis of human autoreactive CD4-positive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Looking and listening to light: the evolution of whole-body photonic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig–coated artificial antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomerase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Intensity of the vaccine-elicited immune response determines tumor clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Phenotypic and functional maturation of tumor antigen-reactive CD8+ T lymphocytes in patients undergoing multiple course peptide vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

T cell vaccines for microbial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Shedding light on immunotherapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Cancer immunotherapy: moving beyond current vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Molecular tracking of antigen-specific T-cell clones during immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Effects of granulocyte-macrophage colony-stimulating factor and foreign helper protein as immunologic adjuvants on the T-cell response to vaccination with tyrosinase peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Aggregation of antigen-specific T cells at the inoculation site of mature dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Cutting Edge: CD8+ Effector T Cells Reject Tumors by Direct Antigen Recognition but Indirect Action on Host Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Frequency of MART-1/MelanA and gp100/PMel17-specific T cells in tumor metastases and cultured tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

HLA class I antigen abnormalities and immune escape by malignant cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Derangement of immune responses by myeloid suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

A guide to choosing fluorescent proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Cancer/testis antigens, gametogenesis and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Efficacy of GM-CSF as an Adjuvant to Hepatitis B Vaccination in Patients with Chronic Renal Failure—Results of a Prospective, Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: effect on cellular and humoral immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Enhanced viral and tumor immunity with intranodal injection of canary pox viruses expressing the melanoma antigen, gp100.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Immunological techniques: ex vivo characterization of T cell-mediated immune responses in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Ex vivo analysis of human antigen-specific CD8+ T-cell responses: quality assessment of fluorescent HLA-A2 multimer and interferon-gamma ELISPOT assays for patient immune monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Rescue of memory CD8+ T cell reactivity in peptide/TLR9 ligand immunization by codelivery of cytokines or CD40 ligation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Tumor-specific shared antigenic peptides recognized by human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Human CD8(+) T-cell differentiation in response to viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Dynamic programming of CD8+ T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Gene profiling of immune responses against tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Enhancing antitumor immune responses: intracellular peptide delivery and identification of MHC class II-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Caveats in the design of MHC class I tetramer/antigen-specific T lymphocytes dissociation assays

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Scaling down imaging: molecular mapping of cancer in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Shedding light onto live molecular targets

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Bioluminescence imaging in living organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Less is more: lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Regulatory T cells in immune surveillance and treatment of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2992005-7

7 January 2021

10.1016/S0065-2776(06)92005-7

Identifiers

DOI

1 reference

3 August 2017

1 reference